What is Chromatography?

Chromatography is the cornerstone of Downstream Bioprocess Engineering, serving as the primary method for purifying valuable biological products produced by cells.

Chromatography is the primary method for purifying biologics in the biopharmaceutical industry, to meet the stringent safety and efficacy standards set forth by federal regulatory agencies, such as the Food & Drug Administration (FDA) and the European Medicines Agency (EMA).

• Definition & Role: Chromatography is a separation technique that exploits differences in molecular properties (size, charge, hydrophobicity, affinity) to isolate the desired biomolecule from impurities.

• Placement in Downstream Processes (DSP): It is typically applied after initial clarification and concentration steps (filtration, centrifugation) to achieve high-purity drug substances.

Importance in the Biopharmaceutical Industry

• Ensures Product Purity & Safety: Biopharmaceuticals such as monoclonal antibodies, vaccines, and recombinant proteins must be free of host cell proteins, DNA, endotoxins, and aggregates. Chromatography provides the precision needed to achieve this.

• Regulatory Compliance: Agencies like the FDA and EMA require rigorous purification standards. Chromatography is the most validated and widely accepted method to meet these requirements.

• Scalability & Flexibility: Modern pre-packed chromatography columns and continuous chromatography systems allow manufacturers to scale downstream processes efficiently, reducing costs and time-to-market.

• Process Intensification: As upstream titers increase, downstream bottlenecks emerge. Chromatography innovations (multi-column continuous systems, membrane chromatography) are critical to intensifying downstream processes and keeping pace with production demands.

• Economic Impact: Chromatography accounts for a significant portion of downstream costs. Optimizing these steps directly influences affordability and accessibility of biologics.

Strategic Significance

Chromatography is not just a purification step—it is a strategic enabler of biopharmaceutical manufacturing process innovation. With biologics approvals rising annually, chromatography ensures that novel therapies reach patients with uncompromised quality.